This survey (n=30) of psychedelic researchers identifies key research gaps in psychedelic harm and safety. It highlights the need to define types of harm, their predictors, and effective treatments. It also calls for better post-psychedelic support, including online resources, peer support, therapy, and psychiatric care. The authors advocate for increased funding, suggesting that psychedelic investors and companies allocate 1% of their investments to safety measures.
Published March 1, 2025
Journal Psychiatric Research & Clinical Practice
Authors Evans, J., Aixalà, M., Anderson, B. T., Brennan, W., Bremler, R., Breeksema, J. J., Burback, L., Calder, A. E., Carhart-Harris, R. L., Cheung, K., Devenot, N., Gorman, I., Greń, J., Hendricks, P. S., Holoyda, B., Jacobs, E., Krecké, J., Kruger, D. J., Luke, D., Majić, T., Mcguire, A. L., Mehtani, N. J., Mathai, D. S., Nash, K., Noorani, T., Palitsky, R., Robinson, O. C., Simonsson, O., Stahre, E., Vanelk, M., Yaden, D. B.